{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:18Z","timestamp":1792276278661,"version":"4.4.0"},"reference-count":21,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[1990,2,1]],"date-time":"1990-02-01T00:00:00Z","timestamp":633830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DICP"],"published-print":{"date-parts":[[1990,2]]},"abstract":"<jats:p>A 74-year-old woman with multiple medical problems including chronic renal failure was admitted for treatment of a diabetic foot infection. On day 12 of therapy with oral ciprofloxacin and metronidazole, the patient experienced generalized myoclonus and muscle twitching. At that time it was realized that although the ciprofloxacin regimen prescribed was a usual dose for a skin and soft-tissue infection, it was excessive for her degree of renal function This was thought to be the most likely cause of the patient's neurotoxicity. Seizure activity has been reported to occur with the quinolone antibiotics and, with the increasing use of these agents, dose reductions should be kept in mind to avoid potentially serious adverse reactions.<\/jats:p>","DOI":"10.1177\/106002809002400204","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T22:04:59Z","timestamp":1498946699000},"page":"138-140","source":"Crossref","is-referenced-by-count":29,"title":["Potential Neurologic Toxicity Related to Ciprofloxacin"],"prefix":"10.1177","volume":"24","author":[{"given":"Marla T.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[1990,2,1]]},"reference":[{"key":"bibr1-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.SD.187"},{"key":"bibr2-106002809002400204","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00003495-198835040-00003","volume":"35","author":"Campou-Richards DM","year":"1988","journal-title":"Drugs"},{"key":"bibr3-106002809002400204","first-page":"381","volume":"82","author":"Arcieri G","year":"1987","journal-title":"Am J Med"},{"key":"bibr4-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1988.tb04058.x"},{"key":"bibr5-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"bibr6-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802200407"},{"key":"bibr7-106002809002400204","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-3-361"},{"key":"bibr8-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1177\/106002808101501101"},{"key":"bibr9-106002809002400204","unstructured":"Physicians' desk reference. 43rd ed. Oradell, NJ: Medical Economics, 1989: 2012\u20136."},{"key":"bibr10-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02957.x"},{"key":"bibr11-106002809002400204","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198700341-00034"},{"key":"bibr12-106002809002400204","first-page":"215","volume":"82","author":"Mulligan ME","year":"1987","journal-title":"Am J Med"},{"key":"bibr13-106002809002400204","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-2-238"},{"key":"bibr14-106002809002400204","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-2-169"},{"key":"bibr15-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90270-3"},{"key":"bibr16-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.Supplement_1.S141"},{"key":"bibr17-106002809002400204","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.2.190"},{"key":"bibr18-106002809002400204","unstructured":"Hori S, Shimada J, Saito A, Miyahara T, Kurioka S, Matsuda M. Inhibitory effect of quinolones on gamma-aminobutyric acid receptor binding (abstract). Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1986: 438."},{"key":"bibr19-106002809002400204","unstructured":"Hori S, Shimada J, Saito A, Miyahara T, Kurioka S, Matsuda M. A study on enhanced epileptogenicity of new quinolones in the presence of anti-inflammatory drugs (abstract). Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1987: 30."},{"key":"bibr20-106002809002400204","first-page":"27","volume-title":"The scientific basis of clinical pharmacology. Principles and examples","author":"Spector R","year":"1986"},{"key":"bibr21-106002809002400204","first-page":"421","volume":"17","author":"Pearson K","year":"1982","journal-title":"Hosp Pharm"}],"container-title":["DICP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809002400204","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809002400204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:03:11Z","timestamp":1777374191000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809002400204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["10.1177\/106002809002400204"],"URL":"https:\/\/doi.org\/10.1177\/106002809002400204","relation":{},"ISSN":["1042-9611"],"issn-type":[{"value":"1042-9611","type":"print"}],"subject":[],"published":{"date-parts":[[1990,2]]}}}